Monopar Therapeutics (MNPR) Return on Capital Employed (2018 - 2025)
Quarterly results put Return on Capital Employed at 12.57% for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was 12.57% (changed N/A YoY), and the annual figure for FY2024 was 54.56%, down 11183.0%.
Monopar Therapeutics has reported Return on Capital Employed over the past 7 years, most recently at 12.57% for Q3 2025.
- Return on Capital Employed reached 12.57% in Q3 2025 per MNPR's latest filing, up from 18.57% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 12.57% in Q3 2025 and bottomed at 131.32% in Q3 2023.
- Median Return on Capital Employed over the past 4 years was 68.1% (2022), compared with a mean of 69.73%.
- The largest annual shift saw Return on Capital Employed crashed -328bps in 2021 before it plummeted -5680bps in 2023.
- Over 4 years, Return on Capital Employed stood at 45.78% in 2021, then crashed by -115bps to 98.41% in 2022, then tumbled by -33bps to 131.32% in 2023, then surged by 90bps to 12.57% in 2025.
- Business Quant data shows Return on Capital Employed for MNPR at 12.57% in Q3 2025, 18.57% in Q2 2025, and 131.32% in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 21.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.19% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.34% |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -12.57% |
| Jun 30, 2025 | -18.57% |
| Sep 30, 2023 | -131.32% |
| Jun 30, 2023 | -118.48% |
| Mar 31, 2023 | -109.99% |
| Dec 31, 2022 | -98.41% |
| Sep 30, 2022 | -75.38% |
| Jun 30, 2022 | -68.10% |
| Mar 31, 2022 | -53.18% |
| Dec 31, 2021 | -45.78% |
| Mar 31, 2021 | -35.31% |
| Dec 31, 2020 | -39.84% |
| Sep 30, 2020 | -36.81% |
| Jun 30, 2020 | -37.43% |
| Mar 31, 2020 | -32.03% |
| Dec 31, 2019 | -50.83% |
| Sep 30, 2019 | -82.68% |
| Jun 30, 2019 | -71.43% |
| Mar 31, 2019 | -58.64% |
| Dec 31, 2018 | -43.85% |
| Sep 30, 2018 | -37.80% |
| Jun 30, 2018 | -202.95% |
| Mar 31, 2018 | -185.17% |